India’s pharmaceutical sector is feeling the heat after U.S. President Donald Trump unveiled a bold plan to cut drug prices by 30-80%. This policy, aimed at making U.S. drug costs match lower prices in other countries, could shake up the 9 billio...
Solara Active Pharma Sciences reported that its Ambernath facility in Maharashtra, having multiple products manufacturing, passed inspection by the United States Food and Drug Administration (USFDA)...
The Centre's latest move to impose a ban on the export of pharmaceuticals to Pakistan, after the April 22 terror attack in Pahalgam, which killed 26 people, will have negligible or no effect on Himachal Pradesh's pharmaceutical industry...
A report from the Drugs Technical Advisory Board's (DTAB) subcommittee, led by Dr. Nilima Kshirsagar, found 16 fixed dose combinations (FDCs) to be irrational and suggested that they be banned because they could endanger human health. The DTAB concur
During a massive crackdown across Telangana, Drug Control Administration (DCA) officials raided 66 pharmacies linked to corporate hospitals; they found a mass violation of regulations including sale of...
Senores Pharmaceuticals Limited, a world class research based pharmaceutical firm has made a disclosure that its 100% owned subsidiary...
FDC Ltd, a drug company from Mumbai, has had to recall more than 60,000 bottles of Timolol Maleate Ophthalmic Solution USP across the US. The trouble started when they found out the bottles were faulty the cap’s spike was getting jammed in the noz...
Empagliflozin, a widely used diabetes medication, after two weeks, went off patent.
Zydus Lifesciences Limited (including its subsidiaries/ affiliates, hereafter referred to as “Zydus”) has received final approval from the United States Food and Drug Administration (USFDA) for Glatiramer Acetate Injection, 20 mg/mL and 40 mg/mL...
PharmaTrac, a market research firm, published data on Eli Lilly’s weight-loss drug Mounjaro has seen rapid growth in India just a month after its launch, with sales of the 2.5 mg injection jumping from Rs. 1.42 crore in March to Rs. 4.8 crore in Apri
, CDSCO.jpg)
